Document ID: chunk:federal_register_of_legislation:F2025C00183:clause:1_73076:p1
Version: federal_register_of_legislation:F2025C00183
Segment Type: clause
Provision Reference: sch 1 cl 73076 (pt 1/2)
Character Range: 262408–265580

73076              Cytology of a liquid‑based cervical or vaginal vault specimen, if the stained cells are examined microscopically or by automated image analysis by or on behalf of a pathologist, if:                                                                                                                                                                                              46.00
                   (a) the cytology is associated with the detection of oncogenic human papillomavirus infection by:
                   (i) a test to which item 73070, 73071, 73074 or 73075 applies; or
                   (ii) a test to which item 73072 applies for a patient mentioned in paragraph (a) or (b) of that item; or
                   (b) the cytology is associated with a test to which item 73072 applies for a patient mentioned in paragraph (c), (d), (e) or (f) of that item; or
                   (c) the cytology is associated with a test to which item 73074 applies; or
                   (d) the test is a repeat of a test to which this item applies, if the specimen collected for the previous test is unsatisfactory; or
                   (e) the cytology is for the follow‑up management of a patient treated for endometrial adenocarcinoma

Division 2.7—Group P7: genetics

2.7.1A  Restriction on item 73287—conjunction with item 73388
  Item 73287 applies to a service described in that item only if the service is not performed in conjunction with a service described in item 73388.

2.7.1B  Restriction on item 73290—conjunction with item 73391
  Item 73290 applies to a service described in that item only if the service is not performed in conjunction with a service described in item 73391.

2.7.1  Restriction on items 73320 and 73321 (HLA‑B27 detection)—services rendered as pathologist‑determinable services
  If a service described in item 73320 or 73321 is rendered as a pathologist‑determinable service, the item does not apply to the service unless the recognised pathologist who renders the service records, in writing:
 (a) the reasons for rendering the service; and
 (b) the result of the service described in item 71147.

2.7.2  Restriction on items 73339 and 73340 (relating to RET gene mutations)
  For any particular patient, items 73339 and 73340 are applicable only once (in total for both items).

2.7.3  Restriction on items 73345 to 73350 (relating to cystic fibrosis)—testing methodology
  A service described in any of items 73345 to 73350 applies to a patient only if the laboratory in which the service is rendered uses a cystic fibrosis transmembrane conductance regulator methodology that:
 (a) has sufficient diagnostic range and sensitivity to detect at least 95% of pathogenic cystic fibrosis transmembrane conductance regulator variants likely to be present in the patient; and
 (b) includes at least 25 of the most frequently encountered cystic fibrosis transmembrane conductance regulator variants in the Australian population.

2.7.3A  Items 73384 to 73387 (relating to pre‑implantation genetic testing)—patient eligibility
  A patient is eligible for a service described in any of items 73384 to 73387 only if:
 (a) the